KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Prepaid Assets: 2011-2024

Historic Prepaid Assets for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Dec 2024 value amounting to $36.1 million.

  • Supernus Pharmaceuticals' Prepaid Assets rose 126.53% to $62.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 million, marking a year-over-year increase of 126.53%. This contributed to the annual value of $36.1 million for FY2024, which is 116.41% up from last year.
  • According to the latest figures from FY2024, Supernus Pharmaceuticals' Prepaid Assets is $36.1 million, which was up 116.41% from $16.7 million recorded in FY2023.
  • In the past 5 years, Supernus Pharmaceuticals' Prepaid Assets registered a high of $36.1 million during FY2024, and its lowest value of $15.8 million during FY2022.
  • For the 3-year period, Supernus Pharmaceuticals' Prepaid Assets averaged around $22.8 million, with its median value being $16.7 million (2023).
  • Per our database at Business Quant, Supernus Pharmaceuticals' Prepaid Assets plummeted by 41.60% in 2022 and then spiked by 116.41% in 2024.
  • Supernus Pharmaceuticals' Prepaid Assets (Yearly) stood at $18.7 million in 2020, then skyrocketed by 44.63% to $27.0 million in 2021, then slumped by 41.60% to $15.8 million in 2022, then increased by 5.68% to $16.7 million in 2023, then skyrocketed by 116.41% to $36.1 million in 2024.